Notice: Users may be experiencing issues with displaying some pages on stanfordhealthcare.org. We are working closely with our technical teams to resolve the issue as quickly as possible. Thank you for your patience.
Nivolumab vs Investigator'S Choice (IC) in Patients With Recurrent or Metastatic (R/M) Squamous Cell Carcinoma of the Head and Neck (SCCHN): Efficacy and Safety in CheckMate 141 by Prior Cetuximab Use Ferris, R. L., Licitra, L., Fayette, J., Even, C., Blumenschein, G., Harrington, K. J., Guigay, J., Vokes, E. E., Saba, N. F., Haddad, R., Ramkumar, S., Russell, J., Brossart, P., Tahara, M., Monga, M., Zhu, J., Colevas, A., Gillison, M. L. WILEY. 2017: 143
View details for Web of Science ID 000413954500207